Evidence map›Paper›PMID 32823501›Full record

ArticleAntibiotics (Basel, Switzerland)2020

A Quantitative Survey of Bacterial Persistence in the Presence of Antibiotics: Towards Antipersister Antimicrobial Discovery.

Jesus Enrique Salcedo-Sora, Douglas B Kell

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Proteostasis-targeted antibacterial strategies.Journal of microbiology (Seoul, Korea) · 2026
    Review
  4. Article
  5. Article
  6. An ecological and stochastic perspective on persisters resuscitation.Computational and structural biotechnology journal · 2025
    Article
  7. Mini review: Persister cell control strategies.Frontiers in pharmacology · 2025
    Review
  8. Article
  9. Bacterial persisters: molecular mechanisms and therapeutic development.Signal transduction and targeted therapy · 2024
    Review
  10. Microbiology spectrum · 2023
    Article
  11. Review
  12. Review
  13. Genome Analysis ofPathogens (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 2 countries.

Jesus Enrique Salcedo-SoraDepartment of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Biosciences Building, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK.ORCID 0000-0002-8756-0080
Douglas B KellDepartment of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Biosciences Building, University of Liverpool, Crown Street, Liverpool L69 7ZB, UK.ORCID 0000-0001-5838-7963
University of Liverpool · GB

Funding

Novo Nordisk NNF10CC1016517
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibioticsbacteriadormancylipopeptidesmembrane transportmembrane transporterspersistersresistancetime–kill

Identifiers

PMID32823501
PMCPMC7460088
OpenAlexW3048430064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.